Sho Kakuto

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Japanese Foundation For Cancer Research(Current)

Sho Kakuto is an author at Japanese Foundation For Cancer Research specializing in immunotherapy, checkpoint inhibitor therapy, and tyrosine kinase inhibition.

ORCID

Publications per year

2023–2024

Publications

Serum CYFRA 21-1 as a Prognostic Marker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

Keiki Miyadera, Sho Kakuto, Mayu Sugai et al. · Cancers · 2024 · 11 citations · Full text

Medicine, Oncology, Pathology +17

Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors

Ryo Ariyasu, Sho Kakuto, Keiki Miyadera et al. · JTO Clinical and Research Reports · 2023 · 10 citations · Full text

Medicine, Oncology, Pharmacology +17

1–2 of 2